Company intelligence / Profile preview

Avosano

Puidoux, Vaud, Switzerland

Ownership: Private
Employees: ~750
Development stage: Commercial

Overview

The company was formed in January 2025 through the combination of Amedis‑UE AG, Voigt AG, and Voigt Industrie Service AG. It provides comprehensive pharmaceutical wholesale and prewholesale services across Switzerland with state-of-the-art infrastructure and rapid delivery capabilities. The group employs approximately 750 people at multiple sites.

Industry: Drug Discovery Services

Partnerships

Formed from partnership/joint venture between Voigt Holding SA and PHOENIX Pharma Switzerland SA

Beyond the preview

Go deeper on Avosano.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avosano.

Explore the full profile